Venous Thromboembolism

FDA Clears Betrixaban For VTE Prophylaxis

FDA Clears Betrixaban For VTE Prophylaxis

By

Fewer VTE events were observed in the betrixaban than enoxaparin arm.

Venous Thromboembolism Risk Elevated in Dialysis Patients

Venous Thromboembolism Risk Elevated in Dialysis Patients

By

VTE is more common among dialysis patients than in the general population, and the risk is highest in the first 6 months after dialysis initiation.

VTE Linked to Higher Death, Graft Loss Risk in Transplant Recipients

VTE Linked to Higher Death, Graft Loss Risk in Transplant Recipients

By

Venous thromboembolism is associated with a 4.1-fold increased risk of death and a 2.3-fold increased risk of death-censored graft loss among kidney transplant recipients.

Sign Up for Free e-newsletters